Clinical Trial Update: Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis

View source ↗

Summary

A completed clinical trial evaluated how Toll-like receptor 2 gene polymorphisms and host immune factors relate to disease severity and treatment response in pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Pulmonary Tuberculosis, Genetic Variants of Host | Status: COMPLETED